Carousel image 1
Carousel image 2
Carousel image 3
Carousel image 4
Carousel image 5
Carousel image 6
Carousel image 7

From Net Confusion to Net Realization - Bursting the GtN Bubble

Gain end-to-end visibility from list to net across rebates, 340B, chargebacks, and assistance. Apply a GtN playbook that solves governance, analytics, and precision contracting. Cut leakage, stabilize forecasts, and grow margin without zero issues.

GtN Problems We Solve for You

Stop GtN complexity from eroding margins & tying-up cash. Practus delivers clarity, control, and enhanced financial performance for Pharma CFOs

1

Lack of Clarity

Navigating the maze of chargebacks, rebates, fees, and accruals feels impossible.

2

Revenue Erosion

Inaccurate accruals, missed rebate validations, and unresolved chargebacks drain your bottom line.

3

Inaccurate Forecasting

Inaccurate GTN forecasting leads to financial surprises and missed targets.

4

Time-Consuming Processes

Manual data entry and reconciliation are slow, error-prone, and inefficient.

Drive Measurable Financial Improvements

Unlock your full financial potential with our data-driven solutions.

15-30%+

Improved GtN Accuracy

Reduce accrual vs. actual variance, leading to more predictable forecasting and fewer financial surprises.

5-10%+

Reduced Revenue Leakage

Identify and recover revenue previously lost to rebate errors, unvalidated deductions and incorrect chargebacks.

8-15 Days

Accelerated Cash Flow

Lower Days Sales Outstanding (DSO) through effective AR cleanup and streamlined dispute resolution.

Up to 30%

Reduced Dispute Volumes

Reduced Chargeback and rebate disputes volume, lowering administrative burden and compliance risk.

25%+

Faster Insights & Reporting

Cut down reporting and analysis time for GtN/AR, enabling quicker, data-driven decisions.

20-35%

Increased Team Efficiency

Reduce manual effort on reconciliation and disputes, freeing up your team for higher-value activities.

Growth: List vs Net Price

List growth slowed from +13.5% (2014) to +2.3% (2024), while net moved from persistent declines to ~+0.1% (2024). The list–net spread narrowed from 8.4 pp (2023) to 2.2 pp (2024)—a meaningful compression.

Indexed Price Growth (2014 = 100)

Source: Drug Channels, 2024

Divergence - All Brands

A seventh straight net decline in 2024

Source: JAMA Network

Follow the GtN Dollar: The Where and the What

Rebates dominate, 340B surges - Don't risk 80% of your revenue

The Real Mix Behind Net

Industry-wide benchmark mix (GtN)

~52-58%
Commercial/PBM rebates & admin fees
~15-18%
340B discounts
~14-17%
Medicaid rebates
~5-7%
Medicare discounts (Coverage Gap)
~4-8%
Other

Therapeutic Class Dynamics

Discount distribution by class, highlighting payer leverage

GtN and the Innovation Squeeze

The growth in the GtN bubble from 2023-2024 is equivalent to the cost of developing 4 new drugs, at $2.6B for each new drug.

340B Concentration

Innovation-Heavy Classes (2021)

RankTherapeutic AreaSpend ($B)Share
1Cancer Drugs$18.139.0%
2Immunosuppressants$6.213.4%
3Anti-Infective Agents$6.614.2%
All Other$15.533.4%
Top 3 Subtotal$30.966.6%
Total$46.4100.0%

Innovation Squeeze Index

GTN ÷ PhRMA R&D

Source: Tufts Center for the Study of Drug Development - Cost of Developing New Drugs, accessed September 17, 2025

340B is Exploding and Destroying Your Margins

340B Purchases Near $80B in 2024—Up 3.5× Since 2017

340B Discounted Purchases (US$B)

Sources: HRSA and DCI, 2024

Let's Solve Your Gross-to-Net Problems

Reduce leakage. Stabilize forecasts. Pass audits.

Revenue erosion

$356B lost to rebates/discounts/fees

GTN / AR Clean-up

Impact 5 · TtV 0–2 months

GTN Process Diagnostics

Impact 4 · TtV 1–3 months

GTN Process Transformation

Impact 4 · TtV 3–6 months

Forecasting volatility

Accrual errors & surprise true-ups

GTN Process Diagnostics

Impact 5 · TtV 1–3 months

GTN Process Transformation

Impact 5 · TtV 3–6 months

Aged AR & DSO

Unapplied cash, duplicates, weak disputes

GTN / AR Clean-up

Impact 5 · TtV 0–2 months

Compliance exposure

Medicaid/340B/IRA errors → penalties

GTN / AR Clean-up

Impact 4 · TtV 0–2 months

GTN Process Diagnostics

Impact 4 · TtV 1–3 months

Operational silos

Finance, Sales Ops, Contracts, 3PL

GTN Process Diagnostics

Impact 3 · TtV 1–3 months

GTN Process Transformation

Impact 3 · TtV 3–6 months

Time-to-Value:

0–2 months
1–3 months
3–6 months

Impact:

Low
High
ProblemGTN / AR Clean-upGTN Process DiagnosticsGTN Process Transformation
Revenue erosionImpact 5 · TtV 0–2 monthsImpact 4 · TtV 1–3 monthsImpact 4 · TtV 3–6 months
Forecasting volatilityImpact 5 · TtV 1–3 monthsImpact 5 · TtV 3–6 months
Aged AR & DSOImpact 5 · TtV 0–2 months
Compliance exposureImpact 4 · TtV 0–2 monthsImpact 4 · TtV 1–3 months
Operational silosImpact 3 · TtV 1–3 monthsImpact 3 · TtV 3–6 months

GTN / AR Clean-up

Transaction triage

Evidence & reconciliation

Controlled resolution

GTN Process Diagnostics

As-Is mapping

Data & doc review

To-Be + roadmap

GTN Process Transformation

Data lake & feeds

Dashboards & alerts

Run & improve

What Our Clients Say

Real stories from leaders we've empowered.

"This service has completely transformed our GtN process. The clarity and control we've gained are unparalleled. We've seen a 5x ROI in the first six months alone."

John Doe

CEO, Acme Inc.

Client Problem

  • Reduce revenue leakage from invalid chargeback claims.
  • Improve the speed and accuracy of claim validation.
  • Enhance visibility into claim status and root causes.

Practus' Role

  • Implemented an automated claim validation engine.
  • Developed a centralized dashboard for real-time tracking.
  • Provided a dedicated team for exception handling and dispute resolution.

Impact Delivered

$5M+

95%

up from 60%

72 hours

down from 2 weeks

"The diagnostics were a game-changer. We identified revenue leakage points we never knew existed and have since recovered millions in unauthorized deductions. I can't recommend them enough."

Jane Smith

CFO, Stark Industries

Impact Delivered

$12M

99.8%

up from 85%

100%

fully prepared for HRSA audits

Client Problem

  • Ensure full compliance with all HRSA regulations.
  • Maximize legitimate 340B savings.
  • Reduce the administrative burden of program management.

Practus' Role

  • Conducted a comprehensive audit of existing 340B processes.
  • Implemented a real-time compliance monitoring system.
  • Provided ongoing support and training for staff.

Turn Data into Insights in 5-Steps

See our data-driven process in action.

Why Practus?

The tools and expertise you need to lead your industry.

AI-Powered Insights

Leverage machine learning to uncover hidden patterns and predict future trends with unparalleled accuracy.

Interactive Dashboards

Visualize your data with stunning, real-time dashboards that are both powerful and easy to use.

Strategic Consulting

Partner with our team of data strategists to turn insights into impactful business actions.

Predictive Analytics

Forecast future outcomes and identify risks and opportunities with our advanced predictive models.

Performance Tracking

Monitor your KPIs in real-time to make data-driven decisions that accelerate growth.

Bespoke Solutions

We build custom analytics solutions tailored to your unique challenges and industry landscape.

Ready to Disrupt?

Let's talk about how we can transform your data into your most valuable asset. Fill out the form to schedule a free consultation with one of our experts.

Email: contact@practus.com

Phone: (555) 123-4567

Request a Consultation

Get in touch with our team.

Practus Logo

© 2024 All Rights Reserved.